FDA inspection
Aurobindo Pharma Limited: FDA inspection ending Mar 9, 2023
FDA inspection 1241780 · Voluntary Action Indicated (VAI) · Medchal
Key facts
| Inspection ID | 1241780 |
|---|---|
| Firm | Aurobindo Pharma Limited |
| FEI number | 3004446312 |
| Address | 314 Medchal - - Malkajgiri District, Unit 12; Survey No |
| City | Medchal |
| Country | India |
| Fiscal year | 2023 |
| Inspection end date | Mar 9, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data